Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
1998-11-9
|
| pubmed:abstractText |
Myelodysplastic syndrome (MDS) is believed to be a stem-cell disorder involving cytopenia and dysplastic changes in three hematopoietic lineages. However, the involvement of pluripotent stem cells and progenitor cells has not been clarified conclusively. To address this issue, we used fluorescence in situ hybridization (FISH) of blood and bone marrow (BM) smears for mature cells and FISH of cells sorted by fluorescence-activated cell sorting for progenitor cells. Seven patients with MDS associated with trisomy 8 were studied. FISH showed +8 in granulocytes, monocytes, and erythroblasts, but not in lymphocytes. Sorted cells of T (CD3(+)), B (CD19(+)), and NK cells (CD3(-)CD56(+)) from peripheral blood did not contain +8, nor did CD34(+) subpopulations from BM including B (CD34(+)CD19(+)), T/NK (CD34(+)CD7(+)) progenitors, and pluripotent stem cells (CD34(+)Thy1(+)). The +8 chromosome abnormality was identified in stem cells only at the level of colony-forming unit of granulocyte-erythrocyte-macrophage-megakaryocyte (CFU-GEMM; CD34(+)CD33(+)). It may thus be concluded that cells affected by trisomy 8 in the context of MDS are at the CFU-GEMM level and that cells of lymphoid lineage are not involved. These results provide new insights into the biology of MDS and suggest that intensive chemotherapy and autologous BM transplantation may become important therapeutic strategies.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0006-4971
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 1998 by The American Society of Hematology.
|
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
92
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2886-92
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:9763574-Adult,
pubmed-meshheading:9763574-Aged,
pubmed-meshheading:9763574-Antigens, CD19,
pubmed-meshheading:9763574-Antigens, CD34,
pubmed-meshheading:9763574-Bone Marrow,
pubmed-meshheading:9763574-Cell Lineage,
pubmed-meshheading:9763574-Cell Separation,
pubmed-meshheading:9763574-Chromosomes, Human, Pair 8,
pubmed-meshheading:9763574-Colony-Forming Units Assay,
pubmed-meshheading:9763574-Female,
pubmed-meshheading:9763574-Flow Cytometry,
pubmed-meshheading:9763574-Hematopoietic Stem Cells,
pubmed-meshheading:9763574-Humans,
pubmed-meshheading:9763574-In Situ Hybridization, Fluorescence,
pubmed-meshheading:9763574-Karyotyping,
pubmed-meshheading:9763574-Male,
pubmed-meshheading:9763574-Middle Aged,
pubmed-meshheading:9763574-Myelodysplastic Syndromes,
pubmed-meshheading:9763574-Trisomy
|
| pubmed:year |
1998
|
| pubmed:articleTitle |
Fluorescence in situ hybridization of progenitor cells obtained by fluorescence-activated cell sorting for the detection of cells affected by chromosome abnormality trisomy 8 in patients with myelodysplastic syndromes.
|
| pubmed:affiliation |
Third Department of Internal Medicine, Akita University School of Medicine, Akita, Japan.
|
| pubmed:publicationType |
Journal Article
|